American Society of Plastic Surgeons
Member Log In
For Medical Professionals
 

Motivation for Revision Rhinoplasty Similar to that of Reconstructive Patients
Ninety-Seven Percent of Patients Satisfied With Revision, Reports Paper in Plastic and Reconstructive Surgery

Arlington Heights, Ill. - Most patients who seek repeated (secondary) cosmetic nose surgeries do so because of new or uncorrected deformities-similar to the reasons for patients undergoing primary rhinoplasty, suggests a report in the September issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

Based on his experience of 150 secondary procedures, ASPS Member Surgeon Mark Constantian, MD, of St. Joseph Hospital and Southern NH Medical Center, Nashua, NH, concludes, "[T]he motivations of secondary rhinoplasty patients resemble those of most other aesthetic and reconstructive patients." His experience questions the perception that patients seeking repeated rhinoplasty are "demanding" or "difficult."

In Most Cases, Secondary Rhinoplasty Is Appropriate

Dr. Constantian performed the secondary procedures over a 16-month period in 2007-08. He analyzed the patients' reasons for surgery, any management issues, the surgeon's and patient's satisfaction with the results, and other issues. The patients were 121 women and 29 men, median age 42 years. They had undergone one to eight previous surgeries, with an average of 3.6 per patient.

For 41 percent of patients, the reason for repeat rhinoplasty was the development of a new deformity-for example, a previously straight nose that had become crooked. In 33 percent, the first rhinoplasty failed to correct the original deformity.

Another 15 percent of patients perceived the loss of desired "personal, familial, or ethnic characteristics." One percent had new or continued problems with airflow obstruction. "Thus the majority (90 percent) sought surgery to correct residual or new deformities, to restore personal characteristics than had been lost, or to correct functional complaints," writes Dr. Constantian.

Only 10 percent of patients were seeking further improvement in an "already acceptable result," as judged by Dr. Constantian. He rated this group of patients as having an average score of about 1 on a 5-point deformity scale, compared to 3 or higher in the other groups.

Dr. Constantian had previously operated on 16 of the patients; in 12 cases, he agreed that the repeat surgery was appropriate. Overall, 14 percent of patients were considered "demanding" by the surgeon and staff, while 27 percent had possible depression. Overall, 97 percent of patients were happy with their outcomes.

Few Patients Have Body Dysmorphic Disorder

Just three patients met criteria for body dysmorphic disorder (BDD)-a psychiatric disorder in which patients have excessive concerns about their physical appearance that interferes with daily life. Previous reports have suggested high rates of BDD among patients undergoing multiple plastic surgery procedures.

Patients seeking second (or more) rhinoplasties are often considered problematic by plastic surgeons. Such patients may be seen as "excessively demanding, often depressed, and impossible to please."

But Dr. Constantian questions those perceptions-his experience suggests that 90 percent of patients have appropriate cosmetic or functional reasons for repeat rhinoplasty. He points out that nearly three-fourths of patients in his study had deformities that either developed after or weren't corrected by the original surgery. "To these patients, the first operation had either been wasted or had done harm."

Dr. Constantian believes that a careful selection process-including evaluation of the patient's expectations and ability to handle possible complications-may have led to a lower rate of "severely unhappy patients" in his practice. Noting the spectrum of body dysmorphic symptoms, he plans a more in-depth analysis of patients who undergo multiple plastic surgeries but fall short of meeting criteria for BDD.

Plastic and Reconstructive Surgery® is published by Lippincott Williams & Wilkins, part of Wolters Kluwer Health.

About Plastic and Reconstructive Surgery

For more than 70 years, Plastic and Reconstructive Surgery® has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair, and cosmetic surgery, as well as news on medico-legal issues.

About ASPS

The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 7,000 Member Surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery. 

About Wolters Kluwer

Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

Logo

Patient Care Center